Refreshed just now
FDA seeks proposals for advanced research and development of regulatory science under FDABAA-27-00123, responses due January 22, 2027.
Why it’s here: An FDA BAA for advanced regulatory science R&D falls under biotechnology policy (FDA regulation of novel therapies), though the description is empty and the scope is unspecified, so relevance is moderate.
Trace across the boardItem
BAAFDA OFFICE OF ACQ GRANT SVCS6d agoFDA seeks proposals for advanced research and development of regulatory science under FDABAA-27-00123, responses due January 22, 2027.Closes in 61 daysFDABAA-27-00123BiotechLifecycle10 linked
Coverage
1 outlets · first seen 12d agoConnected
10 links- MoneyFY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory ScienceBoth involve Food and Drug Administration, Department of Health and Human Services, FDABAA-27-00123
- NewsInside the world of San Francisco 'peptide parties' — including one aboard a World War II shipBoth involve Food and Drug Administration, Department of Health and Human Services
- HillStrategic Planning: FDA Could Further Strengthen Robust IT Modernization PlanBoth involve Food and Drug Administration, Department of Health and Human Services
- NewsTrump administration releases roadmap to boost clinical AIBoth involve Food and Drug Administration, Department of Health and Human Services
- HillEarly-Phase IND Protocol Recommendations for Solid Tumors; Draft Guidance for Industry; AvailabilityBoth involve Food and Drug Administration, Department of Health and Human Services
- NewsCancer Vaccines Are Advancing. Can Regulators Keep Up?Both involve Food and Drug Administration, Department of Health and Human Services
- NewsBill Cassidy says Trump’s FDA pick faces uncertain committee voteBoth involve Food and Drug Administration, Department of Health and Human Services
- MoneyTranslational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)Both involve Food and Drug Administration, Department of Health and Human Services
- NewsSTAT+: FDA rejects Capricor Therapeutics’ Duchenne therapy, a decision that was a long time comingBoth involve Food and Drug Administration
- HillComments due: PSG_218436 - Draft Guidance on RemibrutinibBoth involve Food and Drug Administration
About
- Food and Drug Administration
- Department of Health and Human Services